☆ 4.7 Article

Reincarnated medicines: using out-dated drugs for novel indications

EUROPEAN HEART JOURNAL (2016)

期刊

EUROPEAN HEART JOURNAL

卷 37, 期 33, 页码 2571-2576

出版社

OXFORD UNIV PRESS

DOI: 10.1093/eurheartj/ehw051

关键词

-

类别

Cardiac & Cardiovascular Systems

资金

Fondazione Anna Maria Sechi per il Cuore (FASC), Italy

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Multidisciplinary Sciences

Sounding out falsified medicines from genuine medicines using Broadband Acoustic Resonance Dissolution Spectroscopy (BARDS)

Anas Alfarsi, Celine Caillet, Garry Fawbert, Simon Lawrence, Jacob Kruese, Sean McSweeney, Marcus O'Mahony, Arjen Dondorp, Paul N. Newton, Dara Fitzpatrick

Summary: The trade in falsified medicine is growing rapidly, with potentially harmful consequences for patients. Therefore, effective measures are needed to identify and detect falsified products.

SCIENTIFIC REPORTS (2021)

添加到收藏夹

Article Oncology

Overall survival for oncology drugs approved for genomic indications

Alyson Haslam, Myung Sun Kim, Vinay Prasad

Summary: The study found that only a portion of drugs approved for genomic indications have demonstrated improvements in overall survival and progression-free survival in randomized studies. Drugs approved for BRAF V600 melanoma were more likely to show improvements in overall survival.

EUROPEAN JOURNAL OF CANCER (2022)

添加到收藏夹

Editorial Material Medicine, General & Internal

Fighting the fakes: tackling substandard and falsified medicines

Oksana Zirka Pyzik, Ibrahim Abubakar

Summary: Poor-quality or fraudulent medicines have caused extensive damage to human lives and economies, especially in Africa. This global issue calls for a coordinated response involving stronger regulatory capacities, enhanced surveillance, reporting, and education.

NATURE REVIEWS DISEASE PRIMERS (2022)

添加到收藏夹

Article Medicine, General & Internal

Availability of New Medicines in the US and Germany From 2004 to 2018

Katharina Blankart, Huseyin Naci, Amitabh Chandra

Summary: This study found that fewer new medicines were available in Germany compared with the US between 2004 and 2018, and drugs entered the German market later than in the US.

JAMA NETWORK OPEN (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Medicines, environment and clinical pharmacology

Outi Lapatto-Reiniluoto, Mia Siven, Janne T. Backman, Anneli Torronen

Summary: Medical associations and other societies have emphasized the importance of addressing climate and environmental aspects in medicine. A study with medical students confirmed the suitability of introducing environmental aspects of medicines, suggesting that the same approach can be used for medical professionals. Encouragement is given for clinical pharmacologists, pharmacologists, and pharmacists to participate in discussions on medicine choice strategies in this field.

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2022)

添加到收藏夹

Review Chemistry, Analytical

Analytical Methods for the Quality Control of Veterinary Antimicrobials Medicines

Juliana Ranzan Matos, Sthefane Silva Santos, Rafael de Andrade Inacio Silva, Ricardo Bizogne Souto

Summary: This study reviewed the analytical methods for assessing the quality of veterinary antimicrobial medicines (VAMs) and analyzed regulatory issues and quality control programs. The findings indicate that changes in the potency of VAMs can contribute to the development of microbial resistance. International efforts have been made to ensure the quality of VAMs, but there is still room for improvement in developing new analytical methods and monitoring their quality.

CRITICAL REVIEWS IN ANALYTICAL CHEMISTRY (2023)

添加到收藏夹

Article Public, Environmental & Occupational Health

Multimorbidity and out-of-pocket expenditure for medicines in China and India

Dennis Tuan Vu La, Yang Zhao, Perianayagam Arokiasamy, Rifat Atun, Stewart Mercer, Tiara Marthias, Barbara McPake, Sanghamitra Pati, Raffaele Palladino, John Tayu Lee

Summary: This study analyzed nationally representative survey data from China and India to investigate the distribution and patterns of multimorbidity in relation to socioeconomic status, as well as the association between multimorbidity and out-of-pocket expenditure for medicines by socioeconomic groups. The findings showed that multimorbidity was significantly associated with higher out-of-pocket expenditure for medicines in both countries, highlighting the need for improved financial protection for populations with a higher burden of chronic diseases in low- and middle-income countries.

BMJ GLOBAL HEALTH (2022)

添加到收藏夹

Article Public, Environmental & Occupational Health

The role of pharmacists in eliminating counterfeit medicines in Nigeria

Obi Peter Adigwe

Summary: This study examines the role of pharmacists in preventing and controlling counterfeit pharmaceutical products in Nigeria. The findings highlight the importance of pharmacists in providing education to patients on identifying counterfeit medicines and ensuring that drugs are purchased from credible sources. It also suggests the need for strategic reforms in policy intervention and strengthening the healthcare system.

FRONTIERS IN PUBLIC HEALTH (2023)

添加到收藏夹

Article Oncology

Drug rechanneling: A novel paradigm for cancer treatment

Itishree Kaushik, Sharavan Ramachandran, Sahdeo Prasad, Sanjay K. Srivastava

Summary: Cancer remains a major contributor to the global disease burden, with a low clinical trial success rate. As a result, drug repurposing, which allows expedited access of FDA approved drugs to patients, has gained significant interest among researchers for potential cancer treatments.

SEMINARS IN CANCER BIOLOGY (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Access to medicines for rare diseases: A European regulatory roadmap for academia

Noa Rosenberg, Sibren van den Berg, Nina N. Stolwijk, Bart A. W. Jacobs, Hendrika C. Post, Anna M. G. Pasmooij, Saco J. de Visser, Carla E. M. Hollak

Summary: This paper provides an easily applicable roadmap for academic researchers to make rare disease medicines available for patients. It emphasizes the importance of interaction with regulators and highlights alternative routes for timely access to medicines. Aligning academic studies with regulatory and reimbursement requirements is crucial for improving access to rare disease medicines.

FRONTIERS IN PHARMACOLOGY (2023)

添加到收藏夹

Article Health Care Sciences & Services

What is the out-of-pocket expenditure on medicines in India? An empirical assessment using a novel methodology

Shankar Prinja, Sumit Kumar, Atul Sharma, Sitanshu Sekhar Kar, Narayan Tripathi, Neha Dumka, Sandeep Sharma, Indranil Mukhopadhyay, Saroj Kumar Rana, Samir Garg, Atul Kotwal, Arun Kumar Aggarwal

Summary: This study aimed to determine the extent of medicine expenditure in India. Through interviews and prescription data collection, it was found that household surveys overestimate the share of medicine expenditure.

HEALTH POLICY AND PLANNING (2022)

添加到收藏夹

Article Oncology

Health technology assessment for cancer medicines across the G7 countries and Oceania: an international, cross-sectional study

Kristina Jenei, Adam J. N. Raymakers, Arnaud Bayle, Karin Berger-Thuermel, Avi Cherla, Kazunori Honda, Christopher C. G. A. Jackson, Deme Karikios, Dario Trapani, Scott Berry, Bishal Gyawali

Summary: This study investigates the differences in reimbursement decisions for cancer medicines among economically similar high-income countries. The findings reveal discordance in public reimbursement decisions despite the overlapping evaluation criteria used by these countries. Therefore, there is a need to improve transparency in criteria and learn from other countries' systems to ensure access to high-value cancer medicines and optimize the HTA decision-making process.

LANCET ONCOLOGY (2023)

添加到收藏夹

Review Pharmacology & Pharmacy

The Potential of Traditional Knowledge to Develop Effective Medicines for the Treatment of Leishmaniasis

Luiz Felipe D. Passero, Erika dos Santos Brunelli, Thamara Sauini, Thais Fernanda Amorim Pavani, Jessica Adriana Jesus, Eliana Rodrigues

Summary: Leishmaniasis is a neglected tropical disease with limited therapeutic options and severe side effects from available drugs. Traditional communities in different regions use local natural products as alternative medicines. A bibliographic survey identified 292 plants used for treating leishmaniasis, with Latin America contributing significantly to ethnopharmacological studies on the topic.

FRONTIERS IN PHARMACOLOGY (2021)

添加到收藏夹

Article Oncology

FDA Approvals of Oncology Drugs for Tissue-Agnostic Indications

Marjorie E. E. Zettler

Summary: This study aims to determine the tumor types represented and method of mutation identification in trials supporting FDA approvals of tissue-agnostic drugs, as well as the post-marketing requirements and commitments issued for additional studies and validation of companion diagnostic devices. It was found that between 2017 and 2022, six drugs were approved for seven tissue-agnostic indications, with 9-15 different tumor types represented in the supporting trials. Most drug approvals did not have concurrent approval of a diagnostic test.

TARGETED ONCOLOGY (2023)

添加到收藏夹

Article Chemistry, Multidisciplinary

Redefining the rational use of medicines

Gorka Orive, Saioa Domingo-Echaburu, Unax Lertxundi

Summary: The definition of Rational Use of Drugs has long served as a conceptual framework for health providers worldwide to improve patient's quality of life, but an urgent update is needed to incorporate the philosophy of One-Health.

SUSTAINABLE CHEMISTRY AND PHARMACY (2021)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Anti-anginal drugs-beliefs and evidence: systematic review covering 50 years of medical treatment

Roberto Ferrari, Rita Pavasini, Paolo G. Camici, Filippo Crea, Nicolas Danchin, Fausto Pinto, Athanasios Manolis, Mario Marzilli, Giuseppe M. C. Rosano, Jose Lopez-Sendon, Kim Fox

EUROPEAN HEART JOURNAL (2019)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Grip strength predicts cardiac adverse events in patients with cardiac disorders: an individual patient pooled meta-analysis

Rita Pavasini, Matteo Serenelli, Carlos A. Celis-Morales, Stuart R. Gray, Kazuhiro P. Izawa, Satoshi Watanabe, Eloisa Colin-Ramirez, Lilia Castillo-Martinez, Yasuhiro Izumiya, Shinsuke Hanatani, Yoshiro Onoue, Kenichi Tsujita, Peter S. Macdonald, Sunita R. Jha, Veronique L. Roger, Sheila M. Manemann, Juan Sanchis, Vicente Ruiz, Giulia Bugani, Elisabetta Tonet, Roberto Ferrari, Stefano Volpato, Gianluca Campo

HEART (2019)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Anti-anginal drugs: Systematic review and clinical implications

Rita Pavasini, Paolo G. Camici, Filippo Crea, Nicolas Danchin, Kim Fox, Athanasios J. Manolis, Mario Marzilli, Giuseppe M. C. Rosano, Jose L. Lopez-Sendon, Fausto Pinto, Cristina Balla, Roberto Ferrari

INTERNATIONAL JOURNAL OF CARDIOLOGY (2019)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Intracardiac Flow Analysis: Techniques and Potential Clinical Applications

Donato Mele, Vittorio Smarrazzo, Gianni Pedrizzetti, Fabio Capasso, Marco Pepe, Salvatore Severino, Giovanni Andrea Luisi, Marco Maglione, Roberto Ferrari

JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2019)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Living alone and cardiovascular disease outcomes

Sumeet Gandhi, Shaun G. Goodman, Nicola Greenlaw, Ian Ford, Paula McSkimming, Roberto Ferrari, Yangsoo Jang, Marco Antonio Alcocer-Gamba, Kim Fox, Jean-Claude Tardif, Michal Tendera, Paul Dorian, Gabriel Steg, Jacob Allan Udell

HEART (2019)

添加到收藏夹

Letter Cardiac & Cardiovascular Systems

Generalizability of the REDUCE-IT Trial in Patients With Stable Coronary Artery Disease

Fabien Picard, Deepak L. Bhatt, Gregory Ducrocq, Yedid Elbez, Roberto Ferrari, Ian Ford, Jean-Claude Tardif, Michal Tendera, Kim M. Fox, Philippe Gabriel Steg

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry

Mitja Lainscak, Ivan Milinkovic, Marija Polovina, Marisa G. Crespo-Leiro, Lars H. Lund, Stefan D. Anker, Cecile Laroche, Roberto Ferrari, Andrew J. S. Coats, Theresa McDonagh, Gerasimos Filippatos, Aldo R. Maggioni, Massimo F. Piepoli, Giuseppe M. C. Rosano, Frank Ruschitzka, Dragan Simic, Milika Asanin, Jean-Christophe Eicher, Mehmet B. Yilmaz, Petar M. Seferovic

EUROPEAN JOURNAL OF HEART FAILURE (2020)

添加到收藏夹

Letter Cardiac & Cardiovascular Systems

Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry

Patrick Rossignol, Mitja Lainscak, Maria G. Crespo-Leiro, Cecile Laroche, Massimo F. Piepoli, Gerasimos Filippatos, Giuseppe M. C. Rosano, Gianluigi Savarese, Stefan D. Anker, Petar M. Seferovic, Frank Ruschitzka, Andrew J. S. Coats, Alexandre Mebazaa, Theresa McDonagh, Ana Sahuquillo, Maria Penco, Aldo P. Maggioni, Lars H. Lund

EUROPEAN JOURNAL OF HEART FAILURE (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry

Chris J. Kapelios, Cecile Laroche, Maria G. Crespo-Leiro, Stefan D. Anker, Andrew J. S. Coats, Beatria Diaz-Molina, Gerasimos Filippatos, Mitja Lainscak, Aldo P. Maggioni, Theresa McDonagh, Alexandre Mebazaa, Marco Metra, Brenda Moura, Wilfried Mullens, Massimo F. Piepoli, Giuseppe M. C. Rosano, Frank Ruschitzka, Petar M. Seferovic, Lars H. Lund

EUROPEAN JOURNAL OF HEART FAILURE (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

COX-2 Is Downregulated in Human Stenotic Aortic Valves and Its Inhibition Promotes Dystrophic Calcification

Francesco Vieceli Dalla Sega, Francesca Fortini, Paolo Cimaglia, Luisa Marracino, Elisabetta Tonet, Antonio Antonucci, Marco Moscarelli, Gianluca Campo, Paola Rizzo, Roberto Ferrari

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

添加到收藏夹

Article Medicine, General & Internal

The Combination of Chest Computed Tomography and Standard Electrocardiogram Provides Prognostic Information and Pathophysiological Insights in COVID-19 Pneumonia

Matteo Bertini, Emanuele D'Aniello, Alberto Cereda, Marco Toselli, Filippo Maria Verardi, Luca Rossi, Daniela Aschieri, Alberto Monello, Marco Manfrini, Davide Vignale, Anna Palmisano, Antonio Esposito, Roberto Ferrari, Claudio Rapezzi, Francesco Giannini

Summary: The study discovered that combining chest CT scan and ECG data can improve risk stratification in COVID-19 pneumonia by identifying a distinctive phenotype with both parenchymal and vascular damage of the lung. Patients with severe pneumonia at chest CT scan plus ECG signs of acute RV strain have an extremely poor short-term prognosis.

JOURNAL OF CLINICAL MEDICINE (2021)

添加到收藏夹

Review Medicine, General & Internal

Looking for a Tailored Therapy for Heart Failure: Are We Capable of Treating the Patient Instead of the Disease?

Alessandro Fucili, Paolo Cimaglia, Paolo Severi, Francesco Giannini, Alberto Boccadoro, Marco Micillo, Claudio Rapezzi, Luigi Tavazzi, Roberto Ferrari

Summary: After a decade of stagnation in clinical research for HF treatment, five large randomized trials have recently supported the use of four new classes of drugs, which have proven beneficial for long-term outcomes and quality of life. Beyond their clinical relevance, these novel treatments have different mechanisms of action compared to traditional neuro-hormonal blocking agents. The diverse pathways and solid clinical evidence urge a re-evaluation of HF treatment and personalized drug selection based on patient characteristics.

JOURNAL OF CLINICAL MEDICINE (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Well-Known and Novel Players in Endothelial Dysfunction: Updates on a Notch(ed) Landscape

Francesca Fortini, Francesco Vieceli Dalla Sega, Luisa Marracino, Paolo Severi, Claudio Rapezzi, Paola Rizzo, Roberto Ferrari

Summary: Endothelial dysfunction is a central feature of the cardiovascular continuum, influencing the prognosis and treatment outcomes of cardiovascular diseases. COVID-19-related endothelial dysfunction leads to severe complications, particularly in high-risk individuals with existing endothelial dysfunction.

BIOMEDICINES (2021)

添加到收藏夹

Article Biology

Cardiac Calcifications: Phenotypes, Mechanisms, Clinical and Prognostic Implications

Francesco Vieceli Dalla Sega, Francesca Fortini, Paolo Severi, Paola Rizzo, Iija Gardi, Paolo Cimaglia, Claudio Rapezzi, Luigi Tavazzi, Roberto Ferrari

Summary: This review discusses the pathogenesis and therapeutic approaches of vascular and heart calcifications in different conditions. Calcifications are complex disorders that have significant implications for cardiovascular and kidney diseases.

BIOLOGY-BASEL (2022)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Controversial aspects in the treatment of secondary ischemic mitral insufficiency

Donato Mele, Giovanni Andrea Luisi, Gabriele Pestelli, Vittorio Smarrazzo, Filippo Trevisan, Carlo Savini, Roberto Ferrari

GIORNALE ITALIANO DI CARDIOLOGIA (2019)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.